Order Article Reprints

Richtig G, Kienzl M, Rittchen S, Roula D, Eberle J, Sarif Z, Pichler M, Hoefler G, Heinemann A. Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro. Biology. 2023; 12(5):706. https://doi.org/10.3390/biology12050706

Richtig, Georg, Melanie Kienzl, Sonja Rittchen, David Roula, Jürgen Eberle, Zina Sarif, Martin Pichler, Gerald Hoefler, and Akos Heinemann. 2023. "Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro" Biology 12, no. 5: 706. https://doi.org/10.3390/biology12050706

Richtig, G., Kienzl, M., Rittchen, S., Roula, D., Eberle, J., Sarif, Z., Pichler, M., Hoefler, G., & Heinemann, A. (2023). Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro. Biology, 12(5), 706. https://doi.org/10.3390/biology12050706